Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.
Julia M L
JM
Brotherton
Christopher K
CK
Fairley
Suzanne M
SM
Garland
Dorota
D
Gertig
Marion
M
Saville
D000293:Adolescent; D001315:Australia; D002648:Child; D003430:Cross-Sectional Studies; D015344:DNA Probes, HPV; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006284:Health Plan Implementation / Q000458:organization & administration*; D006801:Humans; D008403:Mass Screening / Q000458:organization & administration; D032541:Mass Vaccination / Q000458:organization & administration*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D015229:Sexually Transmitted Diseases, Viral / Q000453:epidemiology / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D014626:Vaginal Smears; D055815:Young Adult
D015344:DNA Probes, HPV; D053918:Papillomavirus Vaccines